Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) FCF Margin (2016 - 2025)

Mimedx's FCF Margin history spans 15 years, with the latest figure at 20.89% for Q4 2025.

  • For Q4 2025, FCF Margin rose 96.0% year-over-year to 20.89%; the TTM value through Dec 2025 reached 17.56%, down 129.0%, while the annual FY2025 figure was 17.43%, 106.0% down from the prior year.
  • FCF Margin for Q4 2025 was 20.89% at Mimedx, down from 25.62% in the prior quarter.
  • Across five years, FCF Margin topped out at 26.85% in Q3 2023 and bottomed at 17.56% in Q1 2022.
  • The 5-year median for FCF Margin is 8.79% (2024), against an average of 7.42%.
  • The largest annual shift saw FCF Margin skyrocketed 2595bps in 2023 before it tumbled -1053bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 6.36% in 2021, then crashed by -33bps to 8.46% in 2022, then surged by 226bps to 10.68% in 2023, then soared by 87bps to 19.93% in 2024, then grew by 5bps to 20.89% in 2025.
  • Per Business Quant, the three most recent readings for MDXG's FCF Margin are 20.89% (Q4 2025), 25.62% (Q3 2025), and 14.62% (Q2 2025).